Opnext, Inc. (NASDAQ:OPXT) a global leader in optical modules and components, reported that Gilles Bouchard has resigned from his position as Opnext’s Chief Executive Officer and President as well as from his seat on the company’s Board of Directors.

ISTA Pharmaceuticals Inc. (NASDAQ:ISTA) reported the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY™ (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act.

Anworth Mortgage Asset Corporation (NYSE:ANH) reported core earnings available to common stockholders of $22.9 million, or $0.19 per diluted share, for the quarter ended September 30, 2010, consisting primarily of $24.3 million of net income less $1.4 million of dividends paid to our preferred stockholders.

Anworth Mortgage Asset Corporation (NYSE:ANH) reported core earnings available to common stockholders of $22.9 million, or $0.19 per diluted share, for the quarter ended September 30, 2010, consisting primarily of $24.3 million of net income less $1.4 million of dividends paid to our preferred stockholders.